Factors that Influence Treatment and Non-treatment Decision Making Among Individuals with Inflammatory Bowel Disease: An Integrative Review

Patient

Volumn 11, Issue 3, 2018, Pages 271-284

  Kamp, Kendra J ^a   Brittain, Kelly ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS USED IN INFLAMMATORY BOWEL DISEASE;

CLINICAL DECISION MAKING; CROHN DISEASE; DIET; HUMAN; INFLAMMATORY BOWEL DISEASE; INTESTINE SURGERY; NUTRITION; PATIENT ATTITUDE; PATIENT PREFERENCE; PRIORITY JOURNAL; REVIEW; SELF CARE; SOCIAL PSYCHOLOGY; STRESS; SYSTEMATIC REVIEW; ULCERATIVE COLITIS; ADULT; AGED; CHRONIC DISEASE; DECISION MAKING; FEMALE; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PSYCHOLOGY; TREATMENT REFUSAL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; DECISION MAKING; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT PREFERENCE; TREATMENT REFUSAL;

EID: 85046770783     PISSN: 11781653     EISSN: 11781661     Source Type: Journal    
DOI: 10.1007/s40271-017-0294-0     Document Type: Review

References (48)

1. Crohn’s and Colitis Foundation of America. Managing flares and other IBD symptoms. New York: Crohn’s and Colitis Foundation of America; 2009.
2. Crohn’s and Colitis Foundation of America. The facts about inflammatory bowel diseases. New York: Crohn’s and Colitis Foundation of America; 2015.
3. Leitner GC, Vogelsang H. Pharmacological- and non-pharmacological therapeutic approaches in inflammatory bowel disease in adults. World J Gastrointest Pharmacol Ther. 2016;7(1):5–20.
4. Ye Y, et al. The epidemiology and risk factors of inflammatory bowel disease. Int J Clin Exp Med. 2015;8(12):22529–42.
5. Jedel S, et al. A randomized controlled trial of mindfulness-based stress reduction to prevent flare-up in patients with inactive ulcerative colitis. Digestion. 2014;89(2):142–55.
6. Limdi JK, Aggarwal D, McLaughlin JT. Dietary practices and beliefs in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2016;22(1):164–70.
7. Grey M, et al. A revised self- and family management framework. Nurs Outlook. 2015;63(2):162–70.
8. Ryan P, Sawin KJ. The individual and family self-management theory: background and perspectives on context, process, and outcomes. Nurs Outlook. 2009;57(4):217–25.
9. Kaplan GG. The global burden of IBD: from 2015 to 2025. Nature Reviews. Gastroenterol Hepatol. 2015;12(12):720–7.
10. Herman ML, Kane SV. Treatment nonadherence in inflammatory bowel disease: identification, scope, and management strategies. Inflamm Bowel Dis. 2015;21(12):2979–84.
11. Higgins PD, et al. Systematic review: impact of non-adherence to 5-aminosalicylic acid products on the frequency and cost of ulcerative colitis flares. Aliment Pharmacol Ther. 2009;29(3):247–57.
12. Whittemore R, Knafl K. The integrative review: updated methodology. J Adv Nurs. 2005;52(5):546–53.
13. Rini C, et al. Interpersonal influences on patients’ surgical decision making: the role of close others. J Behav Med. 2011;34(5):396–407.
14. Kahn SA, et al. Patient perceptions of fecal microbiota transplantation for ulcerative colitis. Inflamm Bowel Dis. 2013;19(7):1506–13.
15. Allison M, et al. Surgery in young adults with inflammatory bowel disease: a narrative account. Int J Nurs Stud. 2013;50(11):1566–75.
16. Byrne CM, et al. Patient and clinician preferences for surgical and medical treatment options in Ulcerative Colitis. Colorectal Dis. 2014;16(4):285–92.
17. Siegel CA, et al. When should ulcerative colitis patients undergo colectomy for dysplasia? Mismatch between patient preferences and physician recommendations. Inflamm Bowel Dis. 2010;16(10):1658–62.
18. Brown LK, et al. Proximity to disease and perception of utility: physicians’ vs patients’ assessment of treatment options for ulcerative colitis. Dis Colon Rectum. 2011;54(12):1529–36.
19. Bewtra M, et al. Patient preferences for surgical versus medical therapy for ulcerative colitis. Inflamm Bowel Dis. 2014;20(1):103–14.
20. Lichtenstein G, et al. Assessing drug treatment preferences of patients with Crohn’s Disease. Patient: Patient-Cent Outcomes Res. 2010;3(2):113–23.
21. Vavricka SR, et al. Systematic assessment of factors influencing preferences of Crohn’s disease patients in selecting an anti-tumor necrosis factor agent (Choose TNF trial). Inflamm Bowel Dis. 2012;18(8):1523–30.
22. Kim ES, et al. Factors contributing to the preference of Korean patients with Crohn’s disease when selecting an anti-tumor necrosis factor agent (CHOICE Study). Gut Liver. 2016;10(3):391–8.
23. Hodgkins P, et al. Patient preferences for first-line oral treatment for mild-to-moderate ulcerative colitis: a discrete-choice experiment. Patient. 2012;5(1):33–44.
24. Peyrin-Biroulet L, et al. Patient perspectives on biosimilars: a survey by the European Federation of Crohn’s and Ulcerative Colitis associations. J Crohns Colitis. 2017;11(1):128–33.
25. Bewtra M, Johnson FR. Assessing patient preferences for treatment options and process of care in inflammatory bowel disease: a critical review of quantitative data. Patient. 2013;6(4):241–55.
26. Casellas F, et al. Patient preferences for inflammatory bowel disease treatment objectives. Dig Liver Dis. 2017;49(2):152–6.
27. Peyrin-Biroulet L, et al. Treatment satisfaction, preferences and perception gaps between patients and physicians in the ulcerative colitis CARES study: a real world-based study. Dig Liver Dis. 2016;48(6):601–7.
28. van Deen WK, et al. Value redefined for inflammatory bowel disease patients: a choice-based conjoint analysis of patients’ preferences. Qual Life Res. 2017;26(2):455–65.
29. Carpio D, et al. Perception of disease burden and treatment satisfaction in patients with ulcerative colitis from outpatient clinics in Spain: UC-LIFE survey. Eur J Gastroenterol Hepatol. 2016;28(9):1056–64.
30. Siegel CA, et al. Novel statistical approach to determine inflammatory bowel disease: patients’ perspectives on shared decision making. Patient. 2016;9(1):79–89.
31. Kemp K, et al. An exploration of the follow-up up needs of patients with inflammatory bowel disease. J Crohns Colitis. 2013;7(9):e386–95.
32. Vagianos K, et al. What are adults with inflammatory bowel disease (IBD) eating? A closer look at the dietary habits of a population-based Canadian IBD Cohort. J Parenter Enteral Nutr. 2016;40(3):405–11.
33. Zallot C, et al. Dietary beliefs and behavior among inflammatory bowel disease patients. Inflamm Bowel Dis. 2013;19(1):66–72.
34. Schreiber S, et al. Perception gaps between patients with ulcerative colitis and healthcare professionals: an online survey. BMC Gastroenterol. 2012;12:108.
35. Thompson KD, et al. Patients with ulcerative colitis are more concerned about complications of their disease than side effects of medications. Inflamm Bowel Dis. 2016;22(4):940–7.
36. Bernstein KI, et al. Information needs and preferences of recently diagnosed patients with inflammatory bowel disease. Inflamm Bowel Dis. 2011;17(2):590–8.
37. Pittet V, et al. Information needs and concerns of patients with inflammatory bowel disease: what can we learn from participants in a bilingual clinical cohort? PLoS One. 2016;11(3):e0150620.
38. Wong S, et al. The information needs and preferences of persons with longstanding inflammatory bowel disease. Can J Gastroenterol. 2012;26(8):525–31.
39. Johnson FR, et al. Are gastroenterologists less tolerant of treatment risks than patients? Benefit-risk preferences in Crohn’s disease management. J Manag Care Pharm. 2010;16(8):616–28.
40. Keefer L, Kane S. Self-management techniques in IBD. In: Cross RK, Watson AR, editors. Telemanagement of inflammatory bowel disease. Berlin: Springer; 2016. p. 55–70.
41. Khanna R, et al. Endoscopic scoring indices for evaluation of disease activity in Crohn’s disease. Cochrane Database Syst Rev. 2016;8:Cd010642.
42. Novak K, et al. Clinic-based point of care transabdominal ultrasound for monitoring Crohn’s disease: impact on clinical decision making. J Crohns Colitis. 2015;9(9):795–801.
43. Walsh AJ, Bryant RV, Travis SPL. Current best practice for disease activity assessment in IBD. Nat Rev Gastroenterol Hepatol. 2016;13(10):567–79.
44. Muhlbacher AC, Juhnke C. Patient preferences versus physicians’ judgement: does it make a difference in healthcare decision making? Appl Health Econ Health Policy. 2013;11(3):163–80.
45. Goldberg HB, Shorten A. Differences between patient and provider perceptions of informed decision making about epidural analgesia use during childbirth. J Perinat Educ. 2014;23(2):104–12.
46. Tanaka M, et al. Coping strategies for possible flare-ups and their perceived effectiveness in patients with inflammatory bowel disease. Gastroenterol Nurs. 2016;39(1):42–7.
47. Cohan JN, et al. A novel decision aid for surgical patients with ulcerative colitis: results of a pilot study. Dis Colon Rectum. 2016;59(6):520–8.
48. Baker DM, et al. A systematic review of internet decision-making resources for patients considering surgery for ulcerative colitis. Inflamm Bowel Dis. 2017;23(8):1293–300.